IVIM Health vs TMates: Pricing, Access, and Protocols Compared
Quick verdict: IVIM Health emphasizes dual 4.9-star third party ratings, a proprietary GLP-1 ID protocol and promotional free-month offers, while TMates charges a flat $199/month with 24/7 U.S. doctor access and consistent per-dose pricing. This head-to-head look at IVIM Health vs TMates compares pricing, clinical access, protocol approach, reputation and regulatory notes so you can choose more quickly.
Price and membership structure
IVIM Health advertises a free month membership with code GIFT75 and a no-obligation free consultation valued at $75. Published per-month figures on IVIM landing content list compounded semaglutide at $75/mo and tirzepatide at $133/mo with an additional $74.99/mo program fee in some materials and a stated first-month price of $99 with $174/month ongoing in FAQ text. TMates advertises a flat $199/month, the same price at every dose, with examples of multi month plans shown but an explicit flat monthly rate emphasized.
Clinical access and supervision
IVIM Health presents a clinician-guided GLP-1 ID protocol with weekly dose adjustments and clinician oversight; their materials note prescriptions are issued after clinical evaluation. TMates emphasizes 24/7 access to U.S.-based doctors in all 50 states and virtual check-ins, positioning continuous physician availability as a core feature. If around the clock physician access is a priority, TMates specifically highlights that capability.
Protocol approach and claimed outcomes
IVIM promotes a proprietary GLP-1 ID titration and optimization protocol that the company says can accelerate weight loss outcomes by up to 40% compared to standard GLP-1 protocols; the site also cites internal observational studies and a published-study comparison claiming Ivim patients lost an average of 46% more weight over 68 weeks versus a different published clinical trial, with the company noting these are not head to head randomized trials. TMates describes clinically dosed compounded semaglutide with personalized, doctor supervised dosing and positions compounded semaglutide as offering flexibility versus branded options. Both providers present protocol claims; IVIM attributes specific comparative percentages to its proprietary protocol while TMates focuses on steady, supervised dosing and access.
View TMates pricing and access
Reputation, sourcing, and availability
IVIM Health highlights unusually strong third party validation with a 4.9-star rating on both Google and Trustpilot, a point presented as a trust signal. TMates highlights U.S. formulation for its compounded semaglutide and licensed coverage in all 50 states. Both note that compounded medications are not FDA approved and have not undergone FDA review for safety, effectiveness, or quality.
Regulatory and medication details
Both IVIM Health and TMates supply compounded medications and each source explicitly states that compounded drugs are not FDA approved and have not been reviewed by the FDA for safety, effectiveness, or quality. IVIM materials emphasize compounded semaglutide and tirzepatide options and note preparation by independent, licensed compounding pharmacies. TMates describes clinically dosed compounded semaglutide formulated in U.S. based facilities.
Side by side summary
| Criteria | IVIM Health | TMates |
|---|---|---|
| Starting price advertised | $75/mo listed for compounded semaglutide; first month $99 then $174/month ongoing per FAQ; GIFT75 free month available | $199/month flat, same price at every dose |
| Doctor access | Clinician guided GLP-1 ID protocol with clinician evaluation and weekly dose adjustments | 24/7 access to U.S.-based doctors in all 50 states and virtual check-ins |
| Protocol and claims | Proprietary GLP-1 ID protocol claiming up to 40% faster results; internal observational studies cited | Clinically dosed semaglutide with personalized titration; emphasizes steady progress |
| Reputation and sourcing | 4.9-star rating on Google and Trustpilot noted as rare dual verification | Medications formulated in U.S. facilities; licensed in all 50 states |
| Regulatory note | Compounded medications are not FDA approved and not reviewed by FDA | Compounded medications are not FDA approved and not reviewed by FDA |
How to decide: strengths compared
IVIM Health stands out for its dual 4.9-star third party ratings, promotional free month code GIFT75 and an advertised proprietary GLP-1 ID optimization protocol with cited observational results. TMates stands out for a predictable flat $199/month pricing model and explicit 24/7 access to U.S.-based doctors across all 50 states and domestic formulation claims.
Choose based on these facts
Choose IVIM Health if you value third party ratings, want a promotional free month using code GIFT75, and are interested in a proprietary clinician guided GLP-1 ID protocol with cited internal observational analyses. Choose TMates if you prefer a single flat $199/month rate at every dose and round the clock access to U.S.-based doctors and domestic formulation messaging.
Primary comparison keyword: IVIM Health vs TMates